{"id":"NCT00412373","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of Flexible-dose Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2006-12-18","resultsPosted":"2009-12-09","lastUpdate":"2014-05-09"},"enrollment":307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Schizoaffective Disorder","Psychotic Disorder"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Paliperidone ER","otherNames":[]},{"type":"DRUG","name":"Paliperidone ER","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"003","type":"EXPERIMENTAL"},{"label":"002","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to measure the effectiveness and assess the safety of different dosages (from 3 mg/day to 12 mg/day) of the antipsychotic paliperidone extended-release (ER) in patients who are experiencing an acute episode of schizoaffective disorder.","primaryOutcome":{"measure":"Positive and Negative Symptoms of Schizophrenia (PANSS) Total Score at Baseline.","timeFrame":"Baseline","effectByArm":[{"arm":"Placebo","deltaMin":91.7,"sd":12.1},{"arm":"Paliperidone Extended-Release (ER)","deltaMin":92.3,"sd":13.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.774"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":44,"countries":["United States","India","Malaysia","Philippines","Romania","South Korea"]},"refs":{"pmids":["26934062"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=67&filename=CR013099_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":95},"commonTop":["Headache","Dizziness","Insomnia","Dyspepsia","Akathisia"]}}